Mode
Text Size
Log in / Sign up

OB/GYN & Women's Health

244 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Yoga may improve anthropometric, metabolic, endocrine, and psychological outcomes in women with PCOS
OB/GYN & Women's Health Meta-analysis
Yoga may improve anthropometric, metabolic, endocrine, and psychological outcomes in women with PCOS Yoga may help women with Polycystic Ovary Syndrome
This systematic review of nine randomized controlled trials found that yoga interventions were associated with improvements in anthropometri…
A review of trials suggests yoga can improve weight, hormones, and mood for women with Polycystic Ovary Syndrome, but more research is neede…
The Four Cs model offers a coherent way to diagnose and design improvement efforts within healthcare systems today
OB/GYN & Women's Health Guideline
The Four Cs model offers a coherent way to diagnose and design improvement efforts within healthcare systems today New framework helps teams plan better quality improvement projects using four key ideas
This guideline proposes the Four Cs model as a practical framework for diagnosing and designing improvement efforts. It serves as an agenda …
This guide explains a new method called the Four Cs model for planning quality projects. It helps teams understand their work by looking at …
HA-ICSI may slightly reduce miscarriage risk in IVF, but live birth and pregnancy rates show little difference
OB/GYN & Women's Health Sys. Review
HA-ICSI may slightly reduce miscarriage risk in IVF, but live birth and pregnancy rates show little difference Advanced sperm selection shows mixed results for IVF success
This Cochrane systematic review of 5 RCTs with 3752 women found that HA-ICSI probably slightly decreases miscarriage risk compared to standa…
A review of trials finds one advanced sperm method may slightly lower miscarriage risk during IVF, but most techniques show uncertain benefi…
FDA Approves Nexplanon (etonogestrel) for Prevention of Pregnancy for Up to 5 Years
OB/GYN & Women's Health FDA Approval
FDA Approves Nexplanon (etonogestrel) for Prevention of Pregnancy for Up to 5 Years FDA approves Nexplanon implant for long-term birth control up to 5 years.
The FDA approved Nexplanon, a single-rod etonogestrel implant, for prevention of pregnancy in women of reproductive potential for up to 5 ye…
The FDA approved Nexplanon, a small implant placed under the skin of the upper arm, to prevent pregnancy for up to 5 years. It offers a long…
Adjuvant radiotherapy improves recurrence-free survival for intermediate-risk cervical cancer patients after surgery
OB/GYN & Women's Health Meta-analysis
Adjuvant radiotherapy improves recurrence-free survival for intermediate-risk cervical cancer patients after surgery Adjuvant radiotherapy improves recurrence-free survival for early-stage cervical cancer patients
A large meta-analysis of 9,278 patients confirms adjuvant radiotherapy significantly reduces recurrence compared to no further treatment. Co…
A large analysis of nearly 9,300 patients found that adding radiotherapy after surgery reduces the risk of cancer returning without increasi…
Meta-analysis finds higher complication rates with immediate versus delayed breast reconstruction
OB/GYN & Women's Health Meta-analysis
Meta-analysis finds higher complication rates with immediate versus delayed breast reconstruction Meta-analysis shows immediate breast reconstruction linked to higher implant complications
A large meta-analysis shows immediate breast reconstruction carries higher complication rates than delayed procedures, especially with impla…
A large analysis of over 73,000 patients found immediate breast reconstruction had higher complication rates than delayed surgery for implan…
Trastuzumab deruxtecan improves PFS vs chemotherapy in HR-positive, HER2-low breast cancer
OB/GYN & Women's Health RCT
Trastuzumab deruxtecan improves PFS vs chemotherapy in HR-positive, HER2-low breast cancer Trial shows T-DXd beats chemo for breast cancer
In a phase 3 RCT of 866 patients with HR-positive, HER2-low/-ultralow metastatic breast cancer after endocrine therapy, trastuzumab deruxtec…
A new drug, T-DXd, helps people with a common type of advanced breast cancer live longer without their disease getting worse.
TAC chemotherapy improves relapse-free survival in certain early breast cancer subtypes
OB/GYN & Women's Health RCT
TAC chemotherapy improves relapse-free survival in certain early breast cancer subtypes Doctors found that certain tumor markers might help choose the best cancer treatment plan for some patients
A randomized trial compared TAC to ddAC in early breast cancer. The authors observed improved relapse-free survival in specific tumor subtyp…
This study looked at how two different drug schedules worked for people with early breast cancer. Results suggest that specific tumor featur…
Meta-analysis identifies preoperative tumor size and count as key predictors for recurrence following laparoscopic myomectomy in women
OB/GYN & Women's Health Meta-analysis
Meta-analysis identifies preoperative tumor size and count as key predictors for recurrence following laparoscopic myomectomy in women Large fibroids and many fibroids raise recurrence risk after myomectomy surgery
A meta-analysis of 2160 patients reveals that large uterine fibroids and multiple tumors significantly increase recurrence risk after laparo…
A meta-analysis of 2160 patients shows that large preoperative fibroids and multiple fibroids significantly increase the risk of recurrence …
Lymphovenous anastomosis improves quality of life in breast cancer-related lymphedema
OB/GYN & Women's Health Meta-analysis
Lymphovenous anastomosis improves quality of life in breast cancer-related lymphedema Lymphedema surgery improves quality of life in breast cancer survivors
This meta-analysis of observational studies found that therapeutic lymphovenous anastomosis (LVA) significantly improves quality of life in …
A new analysis finds that lymphovenous anastomosis significantly boosts quality of life for breast cancer survivors with lymphedema, especia…
CE-MRI rules out malignancy in 13.1% pretest probability for high-risk breast lesions with 91.3% sensitivity
OB/GYN & Women's Health Meta-analysis
CE-MRI rules out malignancy in 13.1% pretest probability for high-risk breast lesions with 91.3% sensitivity Contrast MRI helps rule out cancer in high-risk breast lesions for many patients
This systematic review and meta-analysis evaluates contrast-enhanced breast MRI (CE-MRI) for ruling out malignancy in patients with high-ris…
A new analysis of 479 patients found that contrast-enhanced MRI could safely rule out cancer in many high-risk breast lesions, potentially a…
FAPI PET shows higher sensitivity and specificity than FDG for cervical cancer diagnosis
OB/GYN & Women's Health Meta-analysis
FAPI PET shows higher sensitivity and specificity than FDG for cervical cancer diagnosis New imaging scan finds cervical cancer better than the standard test
This systematic review and meta-analysis of 109 patients found that fibroblast activation protein inhibitor (FAPI) PET had higher sensitivit…
A new analysis shows a specific scan finds cervical cancer more often than the standard test, helping doctors see the disease earlier in pat…